Open AccessP626: FUNCTIONAL SCREENING OF PI3K INHIBITORS STRATIFIES RESPONDERS TO IDELALISIB AND INDICATES DRUG CLASS ACTIVITY IN IDELALISIB‐REFRACTORY CLL
Author(s) -
Skånland S.,
Yanping Y.,
Athanasiadis P.,
Karlsen L.,
Urban A.,
Murali I.,
Fernandes S.,
Hilli A.,
Taskén K.,
Bertoni F.,
Mato A.,
Normant E.,
Brown J.,
Tjønnfjord G.,
Aittokallio T.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845392.01165.97
Subject(s) - idelalisib , chronic lymphocytic leukemia , venetoclax , pharmacology , cancer research , medicine , leukemia , ibrutinib